Element Acquisition Corporation Announces Formation of Investment Committee LOS ANGELES, June 04, 2020 (GLOBE NEWSWIRE) -- Element Acquisition Corporation (“Element”), a wholly owned division of BioForce Nanosciences Holdings, Inc. (OTC: BFNH), announces that it has created...

Bioforce Nanosciences Holdings, Inc. Announces Its 1 for 5 Reverse Stock Split, Effective February 28, 2020 VIRGINIA BEACH, Va., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Bioforce Nanosciences Holdings, Inc. (BFNH:OTC) (BFNHD:OTC) implemented a 1-for-5 reverse split of its common stock to be effective prior to...

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) Becomes Fully Reporting Per US SEC 1934 Act Rules VIRGINIA BEACH, Va., Aug. 02, 2018 (GLOBE NEWSWIRE) -- BIOFORCE NANOSCIENCES HOLDINGS, INC. (OTCMARKETS:BFNH) announces that the US SEC regulators approved the Company’s FORM 10 registration under...

Get Added Protection Against H3N2 with A.Vogel's Clinically Proven Echinaforce(R) MONTREAL, Feb. 3, 2015 (GLOBE NEWSWIRE) -- A recent study confirms that the 2014-2015 flu vaccine offers little or no protection from this year's predominant influenza strain H3N2. The research,...